Cargando…

Development and evaluation of a patient decision aid for patients considering ongoing medical or surgical treatment options for ulcerative colitis using a mixed-methods approach: protocol for DISCUSS study

INTRODUCTION: Approximately 20%–30% of patients with ulcerative colitis (UC) require surgery, the majority of these being elective due to chronic symptoms refractory to medical treatment. The decision for surgery is difficult and dependent on patient preferences. Current resources for patients consi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baker, Daniel Mark, Lee, Matthew James, Folan, Anne-Mairead, Blackwell, Sue, Robinson, Kerry, Wootton, Rebecca, Sebastian, Shaji, Brown, Steven R, Jones, Georgina Louise, Lobo, Alan J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045112/ https://www.ncbi.nlm.nih.gov/pubmed/31941765 http://dx.doi.org/10.1136/bmjopen-2019-031845

Ejemplares similares

Primary Care in the Spinal Cord Injury Population: Things to Consider in the Ongoing Discussion
por: Gibson-Gill, Carol, et al.
Publicado: (2023)

Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options
por: Bourgonje, Arno R., et al.
Publicado: (2021)

Natural compounds as safe therapeutic options for ulcerative colitis
por: Gupta, Mukta, et al.
Publicado: (2022)

An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
por: Ferretti, Francesca, et al.
Publicado: (2022)

Contribution to the ongoing discussion on fluoride toxicity
por: Guth, Sabine, et al.
Publicado: (2021)

Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new?
por: Andrew, Rachel E, et al.
Publicado: (2016)

Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?
por: Jeon, Seong Ran
Publicado: (2017)

Is Hartmann’s Pouch an Option in the Management of Acute Severe Ulcerative Colitis?
por: Renaud, Myriam, et al.
Publicado: (2022)

Golimumab in the treatment of ulcerative colitis
por: Cunningham, Georgina, et al.
Publicado: (2019)

Oral leukoplakia, the ongoing discussion on definition and terminology
por: van der Waal, Isaäc
Publicado: (2015)

Strontium Chloride: Can It Be a New Treatment Option for Ulcerative Colitis?
por: Topal, Firdevs, et al.
Publicado: (2014)

Transdermal Nicotine as a Treatment Option for Ulcerative Colitis: A Review
por: Kannichamy, Vishmita, et al.
Publicado: (2020)

The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges
por: Noviello, Daniele, et al.
Publicado: (2021)

Expression of Chemokine CCL28 in Ulcerative Colitis Patients
por: Lee, Dong Seok, et al.
Publicado: (2021)

Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis
por: Yoon, Hyuk
Publicado: (2019)

Infliximab: A treatment option for multisystem inflammatory syndrome in children with ulcerative colitis?
por: Alkan, Gulsum, et al.
Publicado: (2021)

Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy
por: Takayama, Tetsuro, et al.
Publicado: (2015)

High prevalence of ulcerative appendicitis in patients with ulcerative colitis
por: Heuthorst, Lianne, et al.
Publicado: (2021)

Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot Study
por: Sebastian, Shaji, et al.
Publicado: (2019)

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
por: Loftus, Edward V, et al.
Publicado: (2022)

Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
por: de Krijger, Manon, et al.
Publicado: (2022)

Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study
por: Kim, Andrew H, et al.
Publicado: (2021)

Small cell carcinoma in ulcerative colitis - new treatment option: a case report
por: Kosmidis, Christoforos, et al.
Publicado: (2010)

Autoimmune Enteropathy in an Ulcerative Colitis Patient
por: Rodriguez, Nicolette J., et al.
Publicado: (2018)

Polymerase chain reaction for detection of mucosal cytomegalovirus infection in patients with acute ulcerative colitis
por: Tun, Gloria S.Z., et al.
Publicado: (2019)

Cytomegalovirus Colitis in a Patient With Ulcerative Colitis on Vedolizumab Monotherapy
por: Meeralam, Yaser, et al.
Publicado: (2023)

A Single-Institution Review of Portosystemic Shunts in Children: An Ongoing Discussion
por: Lillegard, J. B., et al.
Publicado: (2010)

Drain Amylase or Lipase for the Detection of POPF—Adding Evidence to an Ongoing Discussion
por: Müssle, Benjamin, et al.
Publicado: (2019)

ULCERATIVE COLITIS
Publicado: (1969)

Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)
por: Probert, Christopher SJ, et al.
Publicado: (2018)

Reliability of the Endoscopic Ultrasound Ulcerative Colitis (EUS-UC) score for assessment of inflammation in patients with ulcerative colitis
por: Yan, Brian M., et al.
Publicado: (2021)

Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis—Patients’ and Physicians’ View
por: Dubinsky, Marla C, et al.
Publicado: (2021)

Analysis of immunologic comorbidities in ulcerative colitis patients: a tool to prevent exacerbations in ulcerative colitis cases
por: Rodríguez Meza, Miguel Ricardo, et al.
Publicado: (2022)

Quality of Life in Patients with Acute Severe Ulcerative Colitis: Long-Term Follow-Up Results from the CONSTRUCT Trial
por: Alrubaiy, Laith, et al.
Publicado: (2022)

Severe refractory asthma: current treatment options and ongoing research
por: Menzella, Francesco, et al.
Publicado: (2018)

Immunomodulators and Immunosuppressants for Japanese Patients with Ulcerative Colitis
por: Bamba, Shigeki, et al.
Publicado: (2011)

Takayasu's Disease in a Patient with Ulcerative Colitis
por: Chae, Myung Joon, et al.
Publicado: (2013)

The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
por: Seo, Hyun Il, et al.
Publicado: (2014)

IBS-like symptoms in patients with ulcerative colitis
por: Gracie, David J, et al.
Publicado: (2015)

Risk factors for complications in patients with ulcerative colitis
por: Manser, Christine N, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cadod94lgrlom4ha4iae4mn4ns